Acadian Asset Management
CRVO icon

Acadian Asset Management’s CervoMed CRVO Stock Holding History

Acadian Asset Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,049
Closed -$119K – 2244
2020
Q1 		$119K Buy
5,049
+1,738
+52% +$52.7K ﹤0.01% 1316
2019
Q4 		$114K Buy
3,311
+3,084
+1,359% +$188K ﹤0.01% 1417
2019
Q3 		$32K Hold
227
– – ﹤0.01% 1672
2019
Q2 		$48K Buy
+227
New +$61.2K ﹤0.01% 1480

Other funds holding CRVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SAMH
Shanda Asset Management Holdings Tortola,, British Virgin Islands $1.85B AUM 36.09% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Acadian Asset Management's CRVO Position: Q2 2020 in Review

Acadian Asset Management sold out of CervoMed (CRVO) in Q2 2020, closing a stake of 5,049 shares — an estimated $119K sold.

Acadian Asset Management first reported a position in CRVO in Q2 2019 and held it in 4 quarters. The position peaked at $119K in Q1 2020. 22 funds tracked by Wall St. Rank hold CRVO as of Q2 2020.

  • Acadian Asset Management reported no remaining CervoMed position as of Q2 2020 after selling out during the quarter.
  • Acadian Asset Management sold 5,049 CervoMed shares in Q2 2020, an estimated $119K.
  • Acadian Asset Management first reported a position in CervoMed in Q2 2019 and held it in 4 quarters.
  • Acadian Asset Management's CervoMed position peaked at $119K in Q1 2020.
  • 22 funds tracked by Wall St. Rank held CervoMed as of Q2 2020.

Based on Acadian Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.